Gardner Amanda
Int J Health Serv. 2007;37(3):591-3. doi: 10.2190/33N9-23T2-K72T-2LLK.
New research on pharmaceutical-industry sponsorship of clinical research in breast cancer shows that treatment trials funded by the industry are more likely to show positive results than studies sponsored by other sources. There are also major differences in trial design when drug companies are the funders.
一项关于制药行业对乳腺癌临床研究资助情况的新研究表明，由制药行业资助的治疗试验比其他来源资助的研究更有可能得出阳性结果。当制药公司作为资助方时，试验设计也存在重大差异。
